NIBIT-M2: 7-year outcomes and QoL analysis in melanoma patients

(1:42)

NIBIT-M2: 7-year outcomes and QoL analysis in melanoma patients

(54)

Studio NIBIT-M2 in pazienti con metastasi cerebrali da melanoma: ne parla l'oncologa Di Giacomo

(2:3)

Ecco i dati aggiornati del trial NIBIT-M2

(2:10)

ESMO 2020 melanoma roundup

(26:50)

The Art of Detection | A guide to detecting melanoma

(3:20)

AACR 2023 highlights on advances in the treatment of resected high-risk melanoma with Jeffrey Weber

(3:40)

The clinical potential of cellular therapeutics in melanoma

(1:)

8 days before death from metastatic melanoma that went to his brain. Seizure

(7)

Mesothelioma: Old habits, new directions

(18:32)

Cancer: unhinge it from the inside. | Michele Maio | TEDxMilano

(16:9)

What is Stage 0 (in situ) Melanoma?

(3:21)

Daniel P. Petrylak - Clinical Trials in MIBC and NMIBC

(10:33)

Mesothelioma Clinical Trials: Novel and Combination Systemic Therapies

(32:8)

Clinical Cases #32 - Nivolumab nelle metastasi cerebrali da melanoma in un paziente affetto da HIV

(5:49)

Современные возможности второй и последующих линий лекарственной терапии

(15:43)

60-Second Journal Club: Bedaquiline Monotherapy for Multibacillary Leprosy

(1:22)

ESMO 2023 - Tumeurs cutanées

(20:45)